Drugs / Adult Autologous Mesenchymal Bone Marrow Cell
Adult Autologous Mesenchymal Bone Marrow Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02165904 | May 2014 → May 2016 | spinal cord injury | Puerta de Hierro University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adult Autologous Mesenchymal Bone Marrow Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02165904 ↗ |
| Modality | Cell therapy | “first cellular administration” NCT02165904 ↗ |
| Route | Other | “after subarachnoid administration of BMMC” NCT02165904 ↗ |